Combined sub-optimal doses of Rosuvastatin and Bexarotene impairs angiotensin II-induced arterial mononuclear cell adhesion through inhibition of Nox5 signaling pathways and increased RXR/PPARα and RXR/PPARγ interactions
NAGIOS: RODERIC FUNCIONANDO

Combined sub-optimal doses of Rosuvastatin and Bexarotene impairs angiotensin II-induced arterial mononuclear cell adhesion through inhibition of Nox5 signaling pathways and increased RXR/PPARα and RXR/PPARγ interactions

DSpace Repository

Combined sub-optimal doses of Rosuvastatin and Bexarotene impairs angiotensin II-induced arterial mononuclear cell adhesion through inhibition of Nox5 signaling pathways and increased RXR/PPARα and RXR/PPARγ interactions

Show full item record

View       (1.804Mb)

Exportar a Refworks
    
Escudero, Paula; Martinez de Marañón, Aranzazu; Collado, Aida; Gonzalez-Navarro, Herminia; Hermenegildo, Carlos Perfil; Peiró, Concepción; Piqueras, Laura; Sanz, Maria-Jesús
This document is a artículoDate2015

    Escudero, Paula Martinez de Marañón, Aranzazu Collado, Aida Gonzalez-Navarro, Herminia Hermenegildo, Carlos Peiró, Concepción Piqueras, Laura Sanz, Maria-Jesús 2015 Combined sub-optimal doses of Rosuvastatin and Bexarotene impairs angiotensin II-induced arterial mononuclear cell adhesion through inhibition of Nox5 signaling pathways and increased RXR/PPARα and RXR/PPARγ interactions Antioxidants & Redox Signaling 22 901 920
https://doi.org/10.1089/ars.2014.5969

This item appears in the following Collection(s)

Show full item record

Search DSpace

Advanced Search

Browse

Statistics